Previous Article | Next Article 
Applied and Environmental Microbiology, June 2000, p. 2578-2588, Vol. 66, No. 6
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Analysis of the Fecal Microflora of Human Subjects Consuming a
Probiotic Product Containing Lactobacillus rhamnosus
DR20
G. W.
Tannock,1,*
K.
Munro,1
H. J. M.
Harmsen,2
G. W.
Welling,2
J.
Smart,3 and
P. K.
Gopal3
Department of Microbiology, University of
Otago, Dunedin,1 and New Zealand Dairy
Research Institute, Palmerston North,3 New
Zealand, and Department of Medical Microbiology, University
of Groningen, Groningen, The Netherlands2
Received 12 November 1999/Accepted 8 March 2000
 |
ABSTRACT |
The composition of the fecal microflora of 10 healthy subjects was
monitored before (6-month control period), during (6-month test
period), and after (3-month posttest period) the administration of a
milk product containing Lactobacillus rhamnosus DR20 (daily dose, 1.6 × 109 lactobacilli). Monthly fecal samples
were examined by a variety of methods, including bacteriological
culture analysis, fluorescent in situ hybridization with group-specific
DNA probes, denaturing gradient gel electrophoresis of the V2-V3 region
of 16S rRNA genes amplified by PCR, gas-liquid chromatography, and
bacterial enzyme activity analysis. The composition of the
Lactobacillus population of each subject was analyzed by
pulsed-field gel electrophoresis of bacterial DNA digests in order to
differentiate between DR20 and other strains present in the samples.
Representative isolates of lactobacilli were identified to the species
level by sequencing the V2-V3 region of their 16S rRNA genes and
comparing the sequences obtained (BLAST search) to sequences in the
GenBank database. DR20 was detected in the feces of all of the subjects
during the test period, but at different frequencies. The presence of
DR20 among the numerically predominant strains was related to the
presence or absence of a stable indigenous population of lactobacilli
during the control period. Strain DR20 did not persist at levels of
>102 cells per g in the feces of most of the subjects
after consumption of the product ceased; the only exception was one
subject in which this strain was detected for 2 months during the
posttest period. We concluded that consumption of the DR20-containing
milk product transiently altered the Lactobacillus and
enterococcal contents of the feces of the majority of consumers without
markedly affecting biochemical or other bacteriological factors.
 |
INTRODUCTION |
The large bowel of humans is
colonized by a complex microbial community that is often referred to as
the intestinal microflora. This community includes possibly hundreds of
bacterial species, although it is thought that 30 to 40 species account
for 99% of the cells in the community (3). The collection
of bacteria detected in feces reflects the bacteria present in the
distal large bowel, so studies of the human intestinal microflora
usually involve analyses of the bacterial community in fecal samples
(16). Interest in the intestinal microflora has been
stimulated in recent years by the development and marketing of
preparations of living microbial cells that, when consumed, are
believed to influence the composition of the intestinal microflora and
to benefit the well-being of the consumer. These preparations are known
as "probiotics" (5).
Lactobacilli are commonly used as probiotic bacteria. Although greatly
outnumbered by obligately anaerobic bacterial species in the intestinal
tract, lactobacilli are often detected in fecal samples. Indeed,
particular Lactobacillus strains have been found to be
long-term residents of the intestinal tracts of some humans. In other
humans, lactobacilli are undetectable or the strain composition of the
Lactobacillus population changes temporally (11,
13).
Traditionally, the fecal microflora has been analyzed by using
bacteriological culture methods. Although it has been claimed that
approximately 88% of the total microscopic counts of bacterial cells can be cultivated from feces when appropriate techniques are
employed (17), other estimates are less optimistic, and it
is clear that a major proportion of the microflora detected by
microscopy is currently uncultivable (19). Fortunately,
there are molecular techniques which can be used to deal with this
problem; these techniques include fluorescent in situ hybridization
(FISH) performed with DNA probes that target 16S rRNA sequences and PCR which amplifies hypervariable 16S ribosomal DNA (rDNA) sequences coupled with denaturing gel electrophoresis (4, 18, 19). Additionally, microbial metabolic products can be detected and measured
in order to provide indicators of the overall status of the intestinal
microflora (9).
In this paper, we describe the results of a long-term study in which
healthy human subjects consumed a probiotic product containing viable
cells of Lactobacillus rhamnosus DR20, whose probiotic activity influences the natural and adaptive immune systems
(6). We measured the impact of consumption of this probiotic
on the fecal microflora by using a variety of methods, including
selective and nonselective culture techniques, molecular typing of
Lactobacillus isolates, FISH, PCR-denaturing gradient gel
electrophoresis (DGGE), bacterial enzyme analysis, and short-chain
fatty acid analysis.
 |
MATERIALS AND METHODS |
Human subjects, probiotic administration, and sampling.
Ten
healthy subjects (five females and five males) who were between 25 and
55 years old participated in this study, which was approved by the
Southern Regional Health Authority Ethics Committee and was divided
into three parts. The study began with a 6-month control period during
which the subjects consumed daily 32 g of low-lactose, low-fat
milk powder (JENTAL; New Zealand Dairy Board) reconstituted in 250 ml
of cold water. A monthly fecal sample was obtained from each subject.
During the test period that followed, the subjects consumed each day
for 6 months 32 g of reconstituted milk powder that contained
approximately 5.1 × 107 CFU of freeze-dried L. rhamnosus DR20 per g, which resulted in a daily dose of about
1.6 × 109 lactobacilli. The bacteriological
characteristics of DR20 have been described previously by Prasad et al.
(21). Single fecal samples were obtained from each subject
at monthly intervals. Finally, there was a 3-month posttest period
during which the subjects consumed neither reconstituted milk nor
L. rhamnosus DR20. In all other respects, the subjects
maintained their usual food intake and lifestyles. A 4-day food diary
was completed by 9 of the 10 subjects during the posttest period. The
diary was analyzed (to determine the percentages of total energy
obtained from different food groups) by workers at the Department of
Human Nutrition, University of Otago. Eight subjects completed the
entire study, while the other two subjects provided six control period samples but, due to absence overseas, only two test period samples and
one posttest period sample. The numbers of Lactobacillus CFU per gram of probiotic powder were determined throughout the study to
ensure that the appropriate numbers of lactobacilli were present in the
preweighed aliquots of the probiotic preparation, which were stored in
sachets under nitrogen at room temperature. Only lactobacilli were
present in the preparation, and viability did not vary during the study period.
Examination of fecal samples.
Fecal samples were placed in
an anaerobic glove box within 1 h of collection. A weighed sample
(about 1 g) was homogenized in prereduced brain heart infusion
broth and diluted 10-fold to 10
8 in the same medium, as
described previously (13). Portions (100 µl) of each
dilution were spread onto the surfaces of plates which contained the
following agar media and were incubated anaerobically at 37°C:
supplemented brucella blood agar (24) (2 days, total anaerobic CFU), bacteroides bile esculin agar (24) (2 days, Bacteroides fragilis group), egg yolk agar (after equal
volumes of 95% ethanol were added to the dilutions and the
preparations stood for 30 min to select for clostridial spores)
(22) (2 days, clostridia), and Rogosa SL agar (Difco) (2 days for lactobacilli and 4 days for bifidobacteria, after
Lactobacillus colonies were marked at 2 days). The dilutions
were removed from the anaerobic glove box and were used to inoculate
(100-µl inocula) plates which contained the following media and were
incubated aerobically at 37°C: supplemented brucella blood agar (2 days, total aerobic CFU), MacConkey agar (Difco) (1 day,
enterobacteria), bile esculin azide agar (Difco) (1 day, enterococci),
and Sabouraud dextrose agar containing 50 µg of chloramphenicol per
ml (Difco) (2 days, yeasts). To analyze the total
Lactobacillus population, 10 colonies were picked at random
from a dilution agar plate containing about 100 colonies. The isolates
were differentiated by performing pulsed-field gel electrophoresis
(PFGE) of ApaI-digested DNA as described previously (13).
Weighed fecal samples were diluted approximately 1:10 in 0.1 M sodium
phosphate broth (pH 6.5) and used to measure
-glucuronidase activity
(15). Similarly, a fecal homogenate in 0.01 M potassium phosphate buffer (pH 7.0) was used to measure the azoreductase activity
of each sample (14). Suspensions prepared in pH 6.5 buffer
were also used to determine the concentrations of short-chain fatty
acids by gas-liquid chromatography (model GC-17A chromatograph; Shimadzu Corporation, Tokyo, Japan) performed with a DB-FFAP column (J
& W Scientific, Folsum, Calif.) as described by Macfarlane and
colleagues (12).
For the FISH analysis performed with group-specific 16S rRNA-targeted
oligonucleotide probes, six fecal samples (two control
samples, two
test samples, and two posttest samples) from the
eight subjects who
completed the entire study were fixed with
paraformaldehyde and
transported to the University of Groningen
on dry ice. The fixation
method used included homogenization of
0.5 g of feces in 4.5 ml of
phosphate-buffered saline at pH 7.4.
The homogenate was centrifuged at
700 ×
g to remove the large
particles, and then 1 ml
of supernatant was added to 3 ml of a
freshly prepared 4%
paraformaldehyde solution. After storage overnight
at 4°C, the
preparations were stored at

80°C until they were
analyzed. The
following five probes were used to enumerate bacterial
groups in
the fecal samples: Bact338 (total bacteria), Bac303
(
Bacteroides and
Prevotella spp.), Erec482
(
Eubacterium rectale and
Clostridium coccoides),
ELGC01 (gram-positive, low-G+C-content,
group 2 bacteria), Ato291
(
Atopobium,
Eggerthella, and
Collinsella spp.), and Bif164 (
Bifidobacterium
spp.). Samples were also stained
with 4',6-diamidino-2-phenylindole
(DAPI) to obtain total counts.
Harmsen et al. have described the method
used previously (
4;
H. J. M. Harmsen,
A. C. M. Wildeboer-Veloo, J. Grijpstra, J. Knol,
J. E. Degener, and G. W. Welling, submitted for
publication).
Examination of fecal samples by PCR-DGGE.
Three fecal
samples (mid-control period, mid-test period, mid-posttest period) from
each subject were also examined by determining PCR-DGGE profiles. To
extract bacterial DNA, 1 ml of fecal homogenate in pH 7.0 phosphate
buffer (the buffer used for the azoreductase assay) was centrifuged at
14,600 × g for 5 min (5°C). DNA was extracted from
the resulting pellet with a FastDNA kit (BIO 101, Vista, Calif.) by
using CLS-TC (a cell lysis solution used for animal tissues and
bacteria) and a 0.25-in. sphere plus garnet matrix as recommended by
the manufacturer. The V2-V3 region of the 16S rDNA gene (positions 339 to 539 in the Escherichia coli gene) of bacteria in the
fecal samples was amplified by using primers HDA1-GC (5'-CGC CCG
GGG CGC GCC CCG GGC GGG GCG GGG GCA CGG GGG GAC TCC TAC GGG AGG
CAG CAG T-3'; boldface type indicates the GC clamp) and HDA2 (5'-GTA
TTA CCG CGG CTG CTG GCA C-3'). Turner et al. originally described the
HDA primers (S. J. Turner, G. D. Lewis, D. J. Saul,
C. S. Baker, and A. G. Rodrigo, N. Z. Microbiol. Soc.
Annu. Meet., poster paper, 1998). PCR was performed with 0.2-ml tubes
by using a PCR Express thermal cycler (Hybaid, Teddington, United
Kingdom). Each reaction mixture (50 µl) contained reaction buffer (10 mM [final concentration] Tris-HCl, 2.5 mM [final concentration]
MgCl2, 50 mM [final concentration] KCl [pH 8.3]), each
deoxynucleoside triphosphate at a concentration of 200 µM, 20 pmol of
each primer, 1 µl of fecal DNA, and 2.5 U of Taq DNA
polymerase (Boehringer, Mannheim, Germany). The following amplification
program was used: 94°C for 3 min, 30 cycles consisting of 94°C for
30 s, 56°C for 30 s, and 68°C for 60 s, and then 7 min at 68°C. DGGE was performed by using a DCode universal mutation detection system (Bio-Rad, Richmond, Calif.) and gels that were 16 cm
by 16 cm by 1 mm; 6% polyacrylamide gels were prepared and electrophoresed with 1× TAE buffer prepared from 50× TAE buffer (2 M
Tris base, 1 M glacial acetic acid, 50 mM EDTA). The denaturing gradient was formed by using two 6% acrylamide
(acrylamide/bisacrylamide ratio, 37.5:1) stock solutions (Bio-Rad). The
gels contained a 22 to 55% gradient of urea and formamide that
increased in the direction of electrophoresis. A 100% denaturing
solution contained 40% (vol/vol) formamide and 7.0 M urea.
Electrophoresis was performed at 130 V (constant voltage) and 60°C
for about 4.5 h. Electrophoresis was stopped when a xylene cyanol
dye marker reached the bottom of a gel. The gels were stained with an
ethidium bromide solution (5 µg/ml) for 20 min, washed with deionized
water, and viewed by UV transillumination.
DNA extracts from the control period, test period, and posttest period
samples obtained from subject 2 were tested for the
presence of
L. rhamnosus by using PCR and species-specific primers
(
25).
Identification of Lactobacillus isolates.
One
isolate representing each strain detected during the course of the
study was identified to the species level. To do this, we amplified and
sequenced one polynucleotide strand of the V2-V3 region of the 16S rRNA
gene of the isolate and conducted a search of sequences deposited in
the GenBank DNA database by using the BLAST algorithm (1).
The identities of the isolates were determined on the basis of the
highest scores (25). The V2-V3 region was amplified by using
primers HDA1 (lacking the GC clamp) and HDA2 and the thermal cycler
program used for the DGGE analysis, as described above. Sequencing was
carried out by workers at the Centre for Gene Research, University of
Otago, who used the dideoxy method of Sanger et al. (22) and
a PRISM BigDye Ready Reaction terminator cycle sequencing kit (Applied
Biosystems, Inc., Foster City, Calif.) in combination with an Applied
Biosystems model 377A automated sequencing system. Nucleotide sequence
data were analyzed by using the SeqEd program, version 1.0.3 (Applied
Biosystems, Inc.). All of the isolates were catalase negative and
produced lactic acid as the major fermentation product from glucose
(10).
 |
RESULTS |
Bacteriological results.
Consumption of the DR20-containing
reconstituted milk during the test period resulted in a greater
frequency of detection (100%) of lactobacilli in fecal samples
compared to the control period (76%) and posttest period (84%)
samples (Fisher's exact test; P < 0.0001 and
P = 0.0105, respectively). The frequencies of
detection in the control and posttest periods did not differ. The
number of Lactobacillus CFU per gram was higher during
the test period (median, 5.8 log10 CFU/g; range, 4.1 to 9.3 log10 CFU/g; n = 52) than during the
control period (median, 4.5 log10 CFU/g; range, <2.0 to
9.6 log10 CFU/g; n = 60; Mann-Whitney test; P = 0.0004) (Table 1).
The control period and posttest period data (median, 5.3 log10 CFU/g; range, <2.0 to 8.4 log10 CFU/g; n = 26) did not differ
(P = 0.3397). The frequency of detection of
enterococci was greater during the test period than during the control
and posttest periods (98, 85, and 76%, respectively; Fisher's exact
test; P = 0.0191 and P = 0.0048,
respectively). The number of enterococcal CFU was higher during the
test period (median, 5.2 log10 CFU/g; range, <2.0 to 6.9 log10 CFU/g; n = 52) than during the
control period (median, 3.5 log10 CFU/g; range, <2.0 to
7.8 log10 CFU/g; n = 60) or the posttest
period (median, 4.1 log10 CFU/g; range, <2.0 to 7.4 log10 CFU/g; n = 26) (Mann-Whitney test;
P = 0.0006 and P = 0.0161,
respectively) (Table 2). The control
period and posttest period data did not differ (P = 0.9606).
Comparisons of the numbers of total aerobic, bifidobacterial,
lactose-fermenting enterobacterial, clostridial (spores), bacteroides
(esculin-hydrolyzing and non-esculin-hydrolyzing forms were enumerated
separately), and yeast CFU per gram (wet weight) did not reveal
consistent differences in the data for the control, test, and
posttest
periods (Tables
3
through
9). Differences were observed
for some
populations in some subjects, but the differences appeared
to be
idiosyncratic rather than due to the consumption of the
probiotic.
These differences are indicated in footnotes to Tables
4 through
8.
Non-lactose-fermenting enterobacteria were detected
occasionally, but
the occurrence of these bacteria did not differ
in the various periods
of the study (data not shown). The total
anaerobic counts (Table
10) did not differ throughout the study
for most of the subjects; the only exception was subject 5, whose
test
period and posttest period values were higher than the control
period
values (Welch's modified
t test;
P = 0.0173).
The azoreductase and

-glucuronidase values varied widely in most of
the subjects throughout the study, and statistically
significant
differences did not occur as a result of administration
of DR20 (Tables
11 and
12). The only exception was subject 6,
whose azoreductase values were lower during the test period (Welch's
modification of Student's
t test;
P < 0.0100). The concentrations
of short-chain fatty acids were
also highly variable for each
subject, and differences did not occur as
a result of probiotic
administration (Table
13). The acetic acid and butyric acid
concentrations
were consistently lower in the feces of subject 5 than
in the
feces of the other subjects throughout the study.
Composition of the Lactobacillus population as
determined by molecular typing.
L. rhamnosus DR20 was easily
differentiated from other strains of lactobacilli on the basis of
restriction fragment length polymorphic profiles produced by
ApaI digestion of chromosomal DNA (Fig.
1). Molecular typing of isolates obtained
during the study resulted in detection of 41 strains. As we observed
previously (11, 13), each subject harbored a unique
collection of Lactobacillus strains prior to administration
of DR20 and in the posttest period, except that strain L5 was detected
as the numerically dominant strain in both subject 2 and subject 6 (Fig. 2). The isolates obtained from these unrelated subjects had identical PFGE profiles as
generated by both ApaI and SmaI. Furthermore,
they belonged to the same species (see below). Strain L21 was detected
in a single sample from subject 6 and in all but one of the samples from subject 7. These subjects lived in the same residence. L6 was
detected in single samples from subjects 3 and 4. L43 was common in two
posttest period samples from subject 4 but was detected in only one
sample from subject 3. These subjects also lived in the same residence,
so some degree of exposure to common strains of lactobacilli, perhaps
present in food, or "cross-contamination" may have occurred. Strain
L44 was detected in single samples from unrelated subjects 3 and 5, while L12 was detected commonly in subject 5 samples and on a single
occasion in subject 3 samples. Strain DR20 was detected by the culture
technique (>102 CFU per g [wet weight]) in all of the
fecal samples collected from five subjects during the test period, five
of six samples collected during the test period from one subject, two
of six test period samples collected from one subject, and one of six samples collected from two subjects. DR20 was not cultured from the
remaining subject; however, it was detected by PCR performed with
L. rhamnosus-specific primers in fecal samples collected during the test period but not in control or posttest period samples. Thus, consumption of the probiotic preparation resulted in consistent detection of strain DR20 as a numerically dominant member of the Lactobacillus population in six of the subjects,
inconsistent detection in three of the subjects, and detection only as
a subdominant component of the population in one of the subjects (Fig.
2). The number of DR20 CFU per gram (wet weight) of feces could
be calculated for samples in which this strain was numerically
dominant, and the average value was 3.0 × 105 CFU/g.
Taking the average weight of the colon contents as 200 g,
each subject harbored about 6.0 × 107 CFU of DR20 in
the large bowel. DR20 was not detected among the numerically
predominant strains once consumption of the probiotic ceased except in
the case of subject 3, in whom DR20 was detectable for 2 months during
the posttest period. For the six subjects in which DR20 became
numerically dominant during the test period, the strains of
lactobacilli detected in the posttest period were different than the
strains detected in the control period (Fig. 2). The same strains
predominated during the control and posttest periods in the four
subjects whose Lactobacillus population compositions were relatively unchanged during the test period (Fig. 2).

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 1.
PFGE profiles of Lactobacillus strains
isolated from subject 4. Lane 1, L6; lane 2, L17; lane 3, L37; lane 4, L43; lane 5, DR20.
|
|


View larger version (4443K):
[in this window]
[in a new window]
|
FIG. 2.
Graphic representation of the strain compositions of
Lactobacillus populations harbored by 10 human subjects
during the control, test, and posttest periods of the study. For each
graph, the x axis indicates the number of isolates, and the
y axis indicates the sample number. The strains are
identified by numbers, and DR20 is indicated by solid columns.
|
|
Identification of representative isolates of lactobacilli.
The
identities of the 41 strains detected by molecular typing (one
representative isolate of each strain was tested) are shown in Table
14. The majority of the isolates
belonged to the Lactobacillus casei group that contains
L. casei, Lactobacillus paracasei, L. rhamnosus, and Lactobacillus zeae. These species cannot
be distinguished by V2-V3 sequence comparisons.
Comparison of results obtained by bacteriological culturing and
FISH.
The numbers of bacterial cells belonging to the groups
detected with the FISH probes and by DAPI staining did not differ in the control period, test period, and posttest period samples that were
examined (data not shown). The FISH and DAPI data were compared with
the data obtained for the same eight samples by bacteriological analysis in Table 15. Altogether,
the total cell counts were higher when the organisms were detected by
DAPI staining (10.88 ± 0.03 log10 CFU/g [mean ± standard error of the mean]) and with the Bact338 DNA probe
(10.64 ± 0.05 log10 CFU/g) than when they were detected by culture on nonselective medium (10.21 ± 0.05 log10 CFU/g) (Welch's modification of Student's
t test; P < 0.0001). DAPI staining gave
higher counts than analysis with the Bact338 probe (P < 0.0001) for the following reasons: dividing cells may have
contained two DAPI-stained chromosomes which were recognized as two
cells by the automated counting system; the Bact338 probe sequence did
not match sequences in all of the bacterial cells; some bacterial cells
were not sufficiently permeable to the Bact338 probe; and some cells
contained insufficient rRNA targeted by the probe. The bifidobacterial
population data did not differ whether they were obtained by the
culture technique (9.55 ± 0.05 log10 CFU/g) or FISH
(9.43 ± 0.04 log10 CFU/g) (P = 0.1278), nor were the Bacteroides population data
different (culture, 9.23 ± 0.07 log10 CFU/g;
FISH, 9.31 ± 0.05 log10 CFU/g) (P = 0.3691).
Examination of fecal samples by PCR-DGGE.
16S rRNA gene
sequences that were amplified from bacterial DNA extracted from feces
produced profiles in denaturing gradient gels that were characteristic
of each individual (Fig. 3). As described
by Zoetendal and colleagues, some DNA fragments were found in all
individuals and may represent the "core" or "true" fecal
microflora of humans (28). Changes in the profiles during the course of the study were not observed consistently in the subjects,
but the appearance of a fragment in a test period sample from subject 6 and alterations in the posttest period profile of subject 9 compared to
the control and test period profiles of this subject were notable (Fig.
3), as were alterations in the control period profiles of subjects 3 and 10 compared to the test and posttest period profiles of these
subjects (data not shown). The changes observed were probably not
related to probiotic consumption. We have not determined the bacterial
groups responsible for these changes. The V2-V3 fragment of DR20 could
not be detected in the test period samples when the results were
compared to migration of the sequence generated by PCR from a pure
culture of the strain. PCR-DGGE detects 90 to 99% of the numerically
dominant bacterial species in fecal samples according to Zoetendal et
al. (28). Thus, this method is best for monitoring the
populations of obligately anaerobic bacteria present in human feces.

View larger version (144K):
[in this window]
[in a new window]
|
FIG. 3.
PCR-DGGE profiles generated from fecal samples. Lanes 1 through 3, subject 5 control, test, and posttest period samples; lanes
4 through 6, subject 6 samples, showing the appearance of a new 16S
rDNA sequence in the profile during the test period (lane 5, circle);
lanes 7 through 9, subject 7 samples; lanes 10 through 12, subject 9 samples, showing alterations in the profiles (circle) of control and
test period samples compared to the posttest period sample.
|
|
Food diary.
Obvious correlations between consumption of
particular food groups and Lactobacillus population size and
composition were not observed (Table
16).
 |
DISCUSSION |
Consumption of the probiotic product used in this study changed
the fecal microflora of the human subjects in several ways. Lactobacilli and enterococci were detected more frequently and in
higher numbers, and the compositions of the Lactobacillus
populations changed in terms of the numerically predominant strains.
While the increased presence of lactobacilli might have been expected because of the consumption of the probiotic containing L. rhamnosus DR20, the detection of higher numbers of enterococci was
unexpected. It seems likely that the enterococcal population was
influenced by the presence of strain DR20 rather than by the
constituents of the milk powder. Reconstituted milk powder was consumed
during the control period but not during the posttest period. The
enterococci detected in these periods did not differ. Less obvious but
nevertheless noteworthy was the detection of Lactobacillus
acidophilus L35 in the feces of subject 10. This strain
was detected only after consumption of the probiotic commenced
and was undetectable 2 months into the posttest period.
Consistent alterations in the biochemistry of the fecal samples were
not observed as a result of consumption of the probiotic. It has been
reported previously that azoreductase and
-glucuronidase activities
in human feces decrease when a probiotic is consumed (8).
Previous studies of humans have been relatively short, however, and the
degree of fluctuation in these enzyme activities that occurs in human
feces has not been reported previously. Short-term observations could
result in inaccurate predictions of probiotic effects on fecal biochemistry.
Monitoring of the fecal community by FISH and PCR-DGGE
could be useful in future studies of microbial ecology even though these techniques did not detect changes in the microflora that could be
directly related to consumption of the probiotic in this study. It has
been shown that PCR-DGGE detects alterations in the simpler microbial
community in the murine stomach, in which the number of
Lactobacillus cells is much higher than the number of DR20
cells in feces (27). FISH is particularly useful for monitoring the populations of obligate anaerobes for which selective culture media are not available. Both methods have the potential to
detect both cultivable and noncultivable populations. Our results show
that even if good anaerobic bacteriological techniques are used, only
21.4 and 37.5% of the total population detected microscopically (with
DAPI and the Bact338 probe, respectively) can be enumerated by the
culture technique. Overall, the results obtained with the FISH,
PCR-DGGE, and bacteriological culture techniques clearly show that
while long-term consumption of a probiotic altered the Lactobacillus population, it did not affect the populations
of obligate anaerobes which are the numerically dominant members of the
fecal microflora.
In a previous study, Kimura et al. found that about one-half of the
subjects that were investigated harbored a relatively simple
Lactobacillus population in which one or two strains were the numerically predominant isolates throughout the study
(11). We observed the same phenomenon in this study, in
which subjects 2, 6, 7, and 9 were hosts of single dominant strains.
Interestingly, these strains belonged to only two species,
Lactobacillus ruminis (subjects 2 and 6) and
Lactobacillus salivarius subsp. salivarius (subjects 7 and 9). These four subjects consistently harbored Lactobacillus populations containing between 104
and 109 CFU/g throughout the study (Table 1). In contrast,
the feces of subjects 1, 4, 8, and 10 contained widely fluctuating
numbers of lactobacilli, and lactobacilli were undetectable in some
fecal samples (Table 1). Strain DR20 was the predominant
Lactobacillus strain during the test period for subjects
whose Lactobacillus populations fluctuated in terms of size
(subjects 1, 4, 8, and 10) or composition (subject 3) during the
control period (Table 1 and Fig. 2). In these subjects, the strains of
lactobacilli present in the feces during the posttest period were
different than the strains present during the control period, which
emphasized the general instability of the Lactobacillus
populations in these individuals. The probiotic strain was not the
predominant strain in samples collected from subjects whose
Lactobacillus populations were stable (subjects 2, 6, 7, and
9) (Table 1 and Fig. 2). Thus, the presence of lactobacilli (L. ruminis, L. salivarius subsp. salivarius)
that were capable of persisting for a long time in the feces of a
subject appeared to preclude the establishment of DR20 as the
numerically dominant strain. In the future, the results of long-term
control studies such as we describe here might permit predictions of
changes in the fecal microflora to be made prior to consumption of a probiotic.
The important ecological observations described above indicate that the
relationship between Lactobacillus strains and the human
host must be defined. Many of the strains detected in this investigation belonged to the L. casei and
Lactobacillus plantarum groups. We propose that at least a
proportion of these strains detected in feces were transient strains
that originated in food and passed through the intestinal tract. In
ecological terms, these strains were "allochthonous" (strains found
in a place other than where they were formed) with respect to the
intestinal tract. In contrast, the L. ruminis or
L. salivarius subsp. salivarius strains
persisted for at least 18 months in subjects 2, 6, 7, and 9. These
strains could be referred to as "autochthonous" strains (strains inhabiting a place or region from earliest times). As we
observed in our study, strains of probiotic bacteria incorporated into
probiotic products can usually be detected in the feces of human
subjects only while the subjects continue to consume the product
(7). Therefore, their presence in the intestinal tract depends on environmental circumstances (purchase and consumption of the
probiotic). Probiotic bacterial strains should thus be considered
allochthonous. If a strain is derived from a human it may once have
been autochthonous with respect to that individual, but it
is allochthonous with respect to the majority of other humans. There is
a need to introduce this terminology in order to rationalize the
effects of probiotic administration on the consumer relative to the
effects of strains that are already present in the intestinal tract.
Autochthonous strains must be highly compatible with
the intestinal environments of their hosts, since they persist as
members of the Lactobacillus population. They are tolerated
by the immune system of a host to the extent that they are not
eliminated from the intestinal ecosystem. Their interactions with the
host and hence their influence on host characteristics may be entirely
different from the interactions and influence of allochthonous strains.
Berg and Savage (2) noted that Lactobacillus and
Bacteroides strains isolated from the murine intestinal
tract (autochthonous strains) elicited a relatively weak
immune response when they were administered parenterally to mice.
Strains from humans (allochthonous strains) produced a stronger
response in mice. Germfree animals that were monoassociated with
autochthonous lactobacilli or Bacteroides
strains for 1 to 5 weeks did not exhibit evidence of an immune response
to these bacteria. Animals associated with allochthonous strains
exhibited a substantial response (2). The enhanced
phagocytosis and adjuvant effects resulting from administration of some
probiotic strains to rodents and humans may thus reflect the
allochthonous nature of the bacteria (20, 23).
In this study, relatively long-term consumption of DR20 did not result
in consistent alterations in the biochemistry or bacteriology of the
fecal microflora of the 10 human subjects; the only effects were on the
size, frequency of detection, and composition of the Lactobacillus population and the size and frequency of
detection of the enterococcal population. Analysis of the
Lactobacillus populations during the control, test, and
posttest periods of the study, however, led to recognition of the
importance of autochthonous strains of lactobacilli in the
microbial ecology of human feces. Our observations permit reappraisal
of the probiotic concept. Probiotic action may not necessarily be
related to alterations in the composition of the
autochthonous microflora of the large bowel but could have
an effect in the small bowel, where the intestinal ecosystem is first
exposed to the allochthonous microbes. It may now be possible to
replace Fuller's definition of a probiotic ("a live microbial feed
supplement which beneficially affects the host animal by improving its
intestinal microbial balance") (5), which has provided a
useful basis for probiotic research for many years, with a definition
that more accurately reflects microbe-host relationships. "Probiotics
contain microbial cells which transit the gastrointestinal tract and
which, in doing so, benefit the health of the consumer" may be a
suitable definition.
 |
ACKNOWLEDGMENT |
The participation of the subjects in this study is gratefully acknowledged.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, University of Otago, P.O. Box 56, Dunedin, New
Zealand. Phone: 64-3-479-7713. Fax: 64-3-479-8540. E-mail:
gerald.tannock{at}stonebow.otago.ac.nz.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[CrossRef][Medline].
|
| 2.
|
Berg, R. D.
1983.
Host immune response to antigens of the indigenous intestinal flora, p. 101-126.
In
D. J. Hentges (ed.), Human intestinal microflora in health and disease. Academic Press, New York, N.Y.
|
| 3.
|
Drasar, B. S., and P. A. Barrow.
1985.
Intestinal microbiology.
American Society for Microbiology, Washington, D.C.
|
| 4.
|
Franks, A. H.,
H. J. M. Harmsen,
G. C. Raangs,
G. J. Jansen,
F. Schut, and G. W. Welling.
1998.
Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes.
Appl. Environ. Microbiol.
64:3336-3345[Abstract/Free Full Text].
|
| 5.
|
Fuller, R.
1989.
Probiotics in man and animals.
J. Appl. Bacteriol.
66:365-378[Medline].
|
| 6.
|
Gill, H. S.,
K. J. Rutherford,
J. Prasad, and P. K. Gopal.
2000.
Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019).
Br. J. Nutr.
83:167-176[CrossRef][Medline].
|
| 7.
|
Goldin, B. R.,
S. L. Gorbach,
M. Saxelin,
S. Barakat,
L. Gualtieri, and S. Salminen.
1992.
Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.
Dig. Dis. Sci.
37:121-128[CrossRef][Medline].
|
| 8.
|
Goldin, B. R.,
L. Swenson,
J. Dwyer,
M. Sexton, and S. L. Gorbach.
1980.
Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes.
JNCI
64:255-261.
|
| 9.
|
Gordon, H. A., and L. Pesti.
1971.
The gnotobiotic animal as a tool in the study of host-microbial relationships.
Bacteriol. Rev.
35:390-429[Free Full Text].
|
| 10.
|
Holdeman, L. V.,
E. P. Cato, and W. E. C. Moore.
1973.
Anaerobe laboratory manual.
VPI Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg.
|
| 11.
|
Kimura, K.,
A. L. McCartney,
M. A. McConnell, and G. W. Tannock.
1997.
Analysis of fecal populations of bifidobacteria and lactobacilli and investigations of the immunological responses of their human hosts to the predominant strains.
Appl. Environ. Microbiol.
63:3394-3398[Abstract].
|
| 12.
|
Macfarlane, G. T.,
G. R. Gibson, and J. H. Cummings.
1992.
Comparison of fermentation reactions in different regions of the human colon.
J. Appl. Bacteriol.
72:57-64[Medline].
|
| 13.
|
McCartney, A. L.,
W. Wang, and G. W. Tannock.
1996.
Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans.
Appl. Environ. Microbiol.
62:4608-4613[Abstract].
|
| 14.
|
McConnell, M. A., and G. W. Tannock.
1991.
Lactobacilli and azoreductase activity in the murine cecum.
Appl. Environ. Microbiol.
57:3664-3665[Abstract/Free Full Text].
|
| 15.
|
McConnell, M. A., and G. W. Tannock.
1993.
A note on lactobacilli and -glucuronidase activity in the intestinal contents of mice.
J. Appl. Bacteriol.
74:649-651[Medline].
|
| 16.
|
Moore, W. E. C.,
E. P. Cato, and L. V. Holdeman.
1978.
Some current concepts in intestinal bacteriology.
Am. J. Clin. Nutr.
31:S33-S42[Abstract].
|
| 17.
|
Moore, W. E. C., and L. V. Holdeman.
1974.
Special problems associated with the isolation and identification of intestinal bacteria in fecal flora studies.
Am. J. Clin. Nutr.
27:1450-1455[Medline].
|
| 18.
|
Muyzer, G., and K. Smalla.
1998.
Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology.
Antonie Leeuwenhoek
73:127-141[CrossRef][Medline].
|
| 19.
|
O'Sullivan, D. J.
1999.
Methods of analysis of the intestinal microflora, p. 23-44.
In
G. W. Tannock (ed.), Probiotics: a critical review. Horizon Scientific Press, Wymondham, United Kingdom.
|
| 20.
|
Perdigon, G., and S. Alvarez.
1992.
Probiotics and the immune state, p. 146-180.
In
R. Fuller (ed.), Probiotics. The scientific basis. Chapman and Hall, London, United Kingdom.
|
| 21.
|
Prasad, J.,
H. Gill,
J. Smart, and P. K. Gopal.
1998.
Selection and characterisation of lactobacillus and bifidobacterium strains for use as probiotics.
Int. Dairy J.
8:993-1002[CrossRef].
|
| 22.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 23.
|
Schiffrin, E. J.,
F. Rochat,
H. Link-Amster,
J. M. Aeschlimann, and A. Donnet-Hughes.
1995.
Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.
J. Dairy Sci.
78:491-497[Abstract].
|
| 24.
|
Summanen, P.,
E. J. Baron,
D. M. Citron,
C. Strong,
H. Wexler, and S. M. Finegold.
1993.
Wadsworth anaerobic bacteriology manual, 5th ed.
Star Publishing Company, Belmont, Calif.
|
| 25.
|
Tannock, G. W.,
A. Tilsala-Timisjarvi,
S. Rodtong,
J. Ng,
K. Munro, and T. Alatossava.
1999.
Identification of Lactobacillus isolates from the gastrointestinal tract, silage, and yoghurt by 16S-23S rRNA gene intergenic spacer region sequence comparisons.
Appl. Environ. Microbiol.
65:4264-4267[Abstract/Free Full Text].
|
| 26.
|
Tilsala-Timisjarvi, A., and T. Alatossava.
1997.
Development of oligonucleotide primers from the 16S-23S rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR.
Int. J. Food Microbiol.
35:49-56[CrossRef][Medline].
|
| 27.
|
Walter, J.,
G. W. Tannock,
A. Tilsala-Timisjarvi,
S. Rodtong,
D. M. Loach,
K. Munro, and T. Alatossava.
2000.
Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers.
Appl. Environ. Microbiol.
66:297-303[Abstract/Free Full Text].
|
| 28.
|
Zoetendal, E.,
A. D. Akkermans, and W. M. De Vos.
1998.
Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria.
Appl. Environ. Microbiol.
64:3854-3859[Abstract/Free Full Text].
|
Applied and Environmental Microbiology, June 2000, p. 2578-2588, Vol. 66, No. 6
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lebeer, S., Vanderleyden, J., De Keersmaecker, S. C. J.
(2008). Genes and Molecules of Lactobacilli Supporting Probiotic Action. Microbiol. Mol. Biol. Rev.
72: 728-764
[Abstract]
[Full Text]
-
Maukonen, J., Matto, J., Suihko, M.-L., Saarela, M.
(2008). Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol
57: 1560-1568
[Abstract]
[Full Text]
-
Walter, J.
(2008). Ecological Role of Lactobacilli in the Gastrointestinal Tract: Implications for Fundamental and Biomedical Research. Appl. Environ. Microbiol.
74: 4985-4996
[Full Text]
-
Gross, G., Wildner, J., Schonewille, A., Rademaker, J. L. W., van der Meer, R., Snel, J.
(2008). Probiotic Lactobacillus plantarum 299v Does Not Counteract Unfavorable Phytohemagglutinin-Induced Changes in the Rat Intestinal Microbiota. Appl. Environ. Microbiol.
74: 5244-5249
[Abstract]
[Full Text]
-
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., Burcelin, R.
(2008). Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice. Diabetes
57: 1470-1481
[Abstract]
[Full Text]
-
Fastinger, N. D., Karr-Lilienthal, L. K., Spears, J. K., Swanson, K. S., Zinn, K. E., Nava, G. M., Ohkuma, K., Kanahori, S., Gordon, D. T., Fahey, G. C. Jr
(2008). A Novel Resistant Maltodextrin Alters Gastrointestinal Tolerance Factors, Fecal Characteristics, and Fecal Microbiota in Healthy Adult Humans. J. Am. Coll. Nutr.
27: 356-366
[Abstract]
[Full Text]
-
Bibiloni, R., Tandon, P., Vargas-Voracka, F., Barreto-Zuniga, R., Lupian-Sanchez, A., Rico-Hinojosa, M. A., Guban, J., Fedorak, R., Tannock, G. W.
(2008). Differential clustering of bowel biopsy-associated bacterial profiles of specimens collected in Mexico and Canada: what do these profiles represent?. J Med Microbiol
57: 111-117
[Abstract]
[Full Text]
-
Abbas Hilmi, H. T., Surakka, A., Apajalahti, J., Saris, P. E. J.
(2007). Identification of the Most Abundant Lactobacillus Species in the Crop of 1- and 5-Week-Old Broiler Chickens. Appl. Environ. Microbiol.
73: 7867-7873
[Abstract]
[Full Text]
-
Ahmed, S., Macfarlane, G. T., Fite, A., McBain, A. J., Gilbert, P., Macfarlane, S.
(2007). Mucosa-Associated Bacterial Diversity in Relation to Human Terminal Ileum and Colonic Biopsy Samples. Appl. Environ. Microbiol.
73: 7435-7442
[Abstract]
[Full Text]
-
Carroll, I. M., Andrus, J. M., Bruno-Barcena, J. M., Klaenhammer, T. R., Hassan, H. M., Threadgill, D. S.
(2007). Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol.
293: G729-G738
[Abstract]
[Full Text]
-
Li, Y., Canchaya, C., Fang, F., Raftis, E., Ryan, K. A., van Pijkeren, J.-P., van Sinderen, D., O'Toole, P. W.
(2007). Distribution of Megaplasmids in Lactobacillus salivarius and Other Lactobacilli. J. Bacteriol.
189: 6128-6139
[Abstract]
[Full Text]
-
Bibiloni, R., Mangold, M., Madsen, K. L., Fedorak, R. N., Tannock, G. W.
(2006). The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.. J Med Microbiol
55: 1141-1149
[Abstract]
[Full Text]
-
Boyle, R. J, Robins-Browne, R. M, Tang, M. L.
(2006). Probiotic use in clinical practice: what are the risks?. Am. J. Clin. Nutr.
83: 1256-1264
[Abstract]
[Full Text]
-
Kuhbacher, T, Ott, S J, Helwig, U, Mimura, T, Rizzello, F, Kleessen, B, Gionchetti, P, Blaut, M, Campieri, M, Folsch, U R, Kamm, M A, Schreiber, S
(2006). Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut
55: 833-841
[Abstract]
[Full Text]
-
Liong, M. T., Shah, N. P.
(2006). Effects of a Lactobacillus casei Synbiotic on Serum Lipoprotein, Intestinal Microflora, and Organic Acids in Rats. J DAIRY SCI
89: 1390-1399
[Abstract]
[Full Text]
-
Snart, J., Bibiloni, R., Grayson, T., Lay, C., Zhang, H., Allison, G. E., Laverdiere, J. K., Temelli, F., Vasanthan, T., Bell, R., Tannock, G. W.
(2006). Supplementation of the diet with high-viscosity Beta-glucan results in enrichment for lactobacilli in the rat cecum.. Appl. Environ. Microbiol.
72: 1925-1931
[Abstract]
[Full Text]
-
Hagen, K. E., Guan, L. L., Tannock, G. W., Korver, D. R., Allison, G. E.
(2005). Detection, Characterization, and In Vitro and In Vivo Expression of Genes Encoding S-Proteins in Lactobacillus gallinarum Strains Isolated from Chicken Crops. Appl. Environ. Microbiol.
71: 6633-6643
[Abstract]
[Full Text]
-
Holmes, E., Nicholson, J.
(2005). Variation in Gut Microbiota Strongly Influences Individual Rodent Phenotypes. Toxicol Sci
87: 1-2
[Full Text]
-
Ben-Amor, K., Heilig, H., Smidt, H., Vaughan, E. E., Abee, T., de Vos, W. M.
(2005). Genetic Diversity of Viable, Injured, and Dead Fecal Bacteria Assessed by Fluorescence-Activated Cell Sorting and 16S rRNA Gene Analysis. Appl. Environ. Microbiol.
71: 4679-4689
[Abstract]
[Full Text]
-
Lay, C., Rigottier-Gois, L., Holmstrom, K., Rajilic, M., Vaughan, E. E., de Vos, W. M., Collins, M. D., Thiel, R., Namsolleck, P., Blaut, M., Dore, J.
(2005). Colonic Microbiota Signatures across Five Northern European Countries. Appl. Environ. Microbiol.
71: 4153-4155
[Abstract]
[Full Text]
-
Hill, J. E., Hemmingsen, S. M., Goldade, B. G., Dumonceaux, T. J., Klassen, J., Zijlstra, R. T., Goh, S. H., Van Kessel, A. G.
(2005). Comparison of Ileum Microflora of Pigs Fed Corn-, Wheat-, or Barley-Based Diets by Chaperonin-60 Sequencing and Quantitative PCR. Appl. Environ. Microbiol.
71: 867-875
[Abstract]
[Full Text]
-
Walter, J., Chagnaud, P., Tannock, G. W., Loach, D. M., Dal Bello, F., Jenkinson, H. F., Hammes, W. P., Hertel, C.
(2005). A High-Molecular-Mass Surface Protein (Lsp) and Methionine Sulfoxide Reductase B (MsrB) Contribute to the Ecological Performance of Lactobacillus reuteri in the Murine Gut. Appl. Environ. Microbiol.
71: 979-986
[Abstract]
[Full Text]
-
Ballard, S. A., Grabsch, E. A., Johnson, P. D. R., Grayson, M. L.
(2005). Comparison of Three PCR Primer Sets for Identification of vanB Gene Carriage in Feces and Correlation with Carriage of Vancomycin-Resistant Enterococci: Interference by vanB-Containing Anaerobic Bacilli. Antimicrob. Agents Chemother.
49: 77-81
[Abstract]
[Full Text]
-
Jernberg, C., Sullivan, A., Edlund, C., Jansson, J. K.
(2005). Monitoring of Antibiotic-Induced Alterations in the Human Intestinal Microflora and Detection of Probiotic Strains by Use of Terminal Restriction Fragment Length Polymorphism. Appl. Environ. Microbiol.
71: 501-506
[Abstract]
[Full Text]
-
Kliegman, R. M., Willoughby, R. E.
(2005). Prevention of Necrotizing Enterocolitis With Probiotics. Pediatrics
115: 171-172
[Full Text]
-
Yu, Z., Morrison, M.
(2004). Comparisons of Different Hypervariable Regions of rrs Genes for Use in Fingerprinting of Microbial Communities by PCR-Denaturing Gradient Gel Electrophoresis. Appl. Environ. Microbiol.
70: 4800-4806
[Abstract]
[Full Text]
-
Young, S. L., Simon, M. A., Baird, M. A., Tannock, G. W., Bibiloni, R., Spencely, K., Lane, J. M., Fitzharris, P., Crane, J., Town, I., Addo-Yobo, E., Murray, C. S., Woodcock, A.
(2004). Bifidobacterial Species Differentially Affect Expression of Cell Surface Markers and Cytokines of Dendritic Cells Harvested from Cord Blood. CVI
11: 686-690
[Abstract]
[Full Text]
-
Tannock, G. W.
(2004). A Special Fondness for Lactobacilli. Appl. Environ. Microbiol.
70: 3189-3194
[Full Text]
-
Gerbitz, A., Schultz, M., Wilke, A., Linde, H.-J., Scholmerich, J., Andreesen, R., Holler, E.
(2004). Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood
103: 4365-4367
[Abstract]
[Full Text]
-
Schultz, M., Munro, K., Tannock, G. W., Melchner, I., Gottl, C., Schwietz, H., Scholmerich, J., Rath, H. C.
(2004). Effects of Feeding a Probiotic Preparation (SIM) Containing Inulin on the Severity of Colitis and on the Composition of the Intestinal Microflora in HLA-B27 Transgenic Rats. CVI
11: 581-587
[Abstract]
[Full Text]
-
Tannock, G. W., Munro, K., Bibiloni, R., Simon, M. A., Hargreaves, P., Gopal, P., Harmsen, H., Welling, G.
(2004). Impact of Consumption of Oligosaccharide-Containing Biscuits on the Fecal Microbiota of Humans. Appl. Environ. Microbiol.
70: 2129-2136
[Abstract]
[Full Text]
-
Schultz, M., Strauch, U. G., Linde, H.-J., Watzl, S., Obermeier, F., Gottl, C., Dunger, N., Grunwald, N., Scholmerich, J., Rath, H. C.
(2004). Preventive Effects of Escherichia coli Strain Nissle 1917 on Acute and Chronic Intestinal Inflammation in Two Different Murine Models of Colitis. CVI
11: 372-378
[Abstract]
[Full Text]
-
Zoetendal, E. G., Collier, C. T., Koike, S., Mackie, R. I., Gaskins, H. R.
(2004). Molecular Ecological Analysis of the Gastrointestinal Microbiota: A Review. J. Nutr.
134: 465-472
[Abstract]
[Full Text]
-
Nielsen, D. S., Moller, P. L., Rosenfeldt, V., Paerregaard, A., Michaelsen, K. F., Jakobsen, M.
(2003). Case Study of the Distribution of Mucosa-Associated Bifidobacterium Species, Lactobacillus Species, and Other Lactic Acid Bacteria in the Human Colon. Appl. Environ. Microbiol.
69: 7545-7548
[Abstract]
[Full Text]
-
Walter, J., Heng, N. C. K., Hammes, W. P., Loach, D. M., Tannock, G. W., Hertel, C.
(2003). Identification of Lactobacillus reuteri Genes Specifically Induced in the Mouse Gastrointestinal Tract. Appl. Environ. Microbiol.
69: 2044-2051
[Abstract]
[Full Text]
-
De Champs, C., Maroncle, N., Balestrino, D., Rich, C., Forestier, C.
(2003). Persistence of Colonization of Intestinal Mucosa by a Probiotic Strain, Lactobacillus casei subsp. rhamnosus Lcr35, after Oral Consumption. J. Clin. Microbiol.
41: 1270-1273
[Abstract]
[Full Text]
-
Tieking, M., Korakli, M., Ehrmann, M. A., Ganzle, M. G., Vogel, R. F.
(2003). In Situ Production of Exopolysaccharides during Sourdough Fermentation by Cereal and Intestinal Isolates of Lactic Acid Bacteria. Appl. Environ. Microbiol.
69: 945-952
[Abstract]
[Full Text]
-
Gelsomino, R., Vancanneyt, M., Cogan, T. M., Swings, J.
(2003). Effect of Raw-Milk Cheese Consumption on the Enterococcal Flora of Human Feces. Appl. Environ. Microbiol.
69: 312-319
[Abstract]
[Full Text]
-
Stebbings, S., Munro, K., Simon, M. A., Tannock, G., Highton, J., Harmsen, H., Welling, G., Seksik, P., Dore, J., Grame, G., Tilsala-Timisjarvi, A.
(2002). Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford)
41: 1395-1401
[Abstract]
[Full Text]
-
Zoetendal, E. G., Ben-Amor, K., Harmsen, H. J. M., Schut, F., Akkermans, A. D. L., de Vos, W. M.
(2002). Quantification of Uncultured Ruminococcus obeum-Like Bacteria in Human Fecal Samples by Fluorescent In Situ Hybridization and Flow Cytometry Using 16S rRNA-Targeted Probes. Appl. Environ. Microbiol.
68: 4225-4232
[Abstract]
[Full Text]
-
Zoetendal, E. G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A. D. L., de Vos, W. M.
(2002). Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces. Appl. Environ. Microbiol.
68: 3401-3407
[Abstract]
[Full Text]
-
Marcille, F., Gomez, A., Joubert, P., Ladire, M., Veau, G., Clara, A., Gavini, F., Willems, A., Fons, M.
(2002). Distribution of Genes Encoding the Trypsin-Dependent Lantibiotic Ruminococcin A among Bacteria Isolated from Human Fecal Microbiota. Appl. Environ. Microbiol.
68: 3424-3431
[Abstract]
[Full Text]
-
Requena, T., Burton, J., Matsuki, T., Munro, K., Simon, M. A., Tanaka, R., Watanabe, K., Tannock, G. W.
(2002). Identification, Detection, and Enumeration of Human Bifidobacterium Species by PCR Targeting the Transaldolase Gene. Appl. Environ. Microbiol.
68: 2420-2427
[Abstract]
[Full Text]
-
Favier, C. F., Vaughan, E. E., De Vos, W. M., Akkermans, A. D. L.
(2002). Molecular Monitoring of Succession of Bacterial Communities in Human Neonates. Appl. Environ. Microbiol.
68: 219-226
[Abstract]
[Full Text]
-
Walter, J., Hertel, C., Tannock, G. W., Lis, C. M., Munro, K., Hammes, W. P.
(2001). Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella Species in Human Feces by Using Group-Specific PCR Primers and Denaturing Gradient Gel Electrophoresis. Appl. Environ. Microbiol.
67: 2578-2585
[Abstract]
[Full Text]
-
McCracken, V. J., Simpson, J. M., Mackie, R. I., Gaskins, H. R.
(2001). Molecular Ecological Analysis of Dietary and Antibiotic-Induced Alterations of the Mouse Intestinal Microbiota. J. Nutr.
131: 1862-1870
[Abstract]
[Full Text]
-
Kaplan, C. W., Astaire, J. C., Sanders, M. E., Reddy, B. S., Kitts, C. L.
(2001). 16S Ribosomal DNA Terminal Restriction Fragment Pattern Analysis of Bacterial Communities in Feces of Rats Fed Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol.
67: 1935-1939
[Abstract]
[Full Text]
-
Sheih, Y.-H., Chiang, B.-L., Wang, L.-H., Liao, C.-K., Gill, H. S.
(2001). Systemic Immunity-Enhancing Effects in Healthy Subjects Following Dietary Consumption of the Lactic Acid Bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr.
20: 149-156
[Abstract]
[Full Text]
-
Simpson, J. M., McCracken, V. J., Gaskins, H. R., Mackie, R. I.
(2000). Denaturing Gradient Gel Electrophoresis Analysis of 16S Ribosomal DNA Amplicons To Monitor Changes in Fecal Bacterial Populations of Weaning Pigs after Introduction of Lactobacillus reuteri Strain MM53. Appl. Environ. Microbiol.
66: 4705-4714
[Abstract]
[Full Text]